The pathogenesis and prognostic factors of scleritis

The pathogenesis and prognostic factors of scleritis - The pathogenesis of scleritis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55201

Enrollment

245

Registered

2020-03-10

Start date

2020-04-29

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleritis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with scleritis with a minimum age of 18 years.

Exclusion criteria

Exclusion criteria: Patients who are younger than 18 years old, who are mentally not competent, or patients with insufficient knowledge of the Dutch language.

Design outcomes

Primary

Measure	Time frame
The main study parameter is the difference in prevalence of specific auto-antibodies between patients with scleritis and controls.	—

Secondary

Measure	Time frame
Other study parameters are the differences between presence of MMPs, specific biomarkers and HLA associations between patients and controls.	—

Countries

Netherlands

Outcome results